SUN-037 Discordant Serum 17-hydroxyprogesterone and Androstenedione in the Management of Congenital Adrenal Hyperplasia: Are 11-oxygenated Androgens Useful?

Background 21-hydroxylase-deficiency (21OHD) accounts for more than 95% of CAH cases. Serum 17-hydroxyprogesteron (17OHP) and androstenedione (A4) are traditional biomarkers for monitoring therapy. While generally there is good linear correlation between 17OHP and A4, physicians are likely to encoun...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Jha, Smita, Turcu, Adina F, Sinaii, Ninet, Brookner, Brittany, Veeraraghavan, Padmasree, Mallappa, Ashwini, Auchus, Richard Joseph, Merke, Deborah P
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Reproductive Endocrinology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207767/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1756
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares